Financhill
Back

111 Quote, Financials, Valuation and Earnings

111 Price Quote

$0.87
-0.01 (15.63%)
(Updated: December 21, 2024 at 5:55 AM ET)

111 Key Stats

Sell
41
111 (YI) is a Sell

Day range:
$0.74 - $0.90
52-week range:
$0.55 - $1.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.04
P/B ratio:
0%

Volume:
183.5K
Avg. volume:
155.3K
1-year change:
-41.14%
Market cap:
$75.4M
Revenue:
$2.1B
EPS:
$-0.44

How Much Does 111 Make?

Data Unavailable

Is 111 Growing As A Company?

Data Unavailable

111 Stock Price Performance

  • Did 111 Stock Go Up Last Month?
    111 share price went up by 44.55% last month
  • Did YI's Share Price Rise Over The Last Year?
    YI share price fell by -41.14% over the past 1 year

What Is 111 52-Week High & Low?

  • What Is 111’s 52-Week High Share Price?
    111 has traded as high as $1.85 over the past 52 weeks
  • What Is 111’s 52-Week Low Share Price?
    111 has traded as low as $0.55 over the past 52 weeks

111 Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy 111?

Data Unavailable

Is 111 Cash Flow Positive?

Data Unavailable

111 Return On Invested Capital

Data Unavailable

111 Earnings Date & Stock Price

  • What Is 111's Stock Price Today?
    A single share of YI can be purchased today for 0.88
  • What Is 111’s Stock Symbol?
    111 trades on the nasdaq under the ticker symbol: YI
  • When Is 111’s Next Earnings Date?
    The next quarterly earnings date for 111 is scheduled on March 21, 2025
  • When Is YI's next ex-dividend date?
    111's next ex-dividend date is December 22, 2024
  • How To Buy 111 Stock?
    You can buy 111 shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

111 Competitors

  • Who Are 111's Competitors?
    Below is a list of companies who compete with 111 or are related in some way:
    • Concord Medical Services Holdings Ltd (CCM)
    • China Pharma Holding Inc (CPHI)
    • Dr Reddy's Laboratories Ltd (RDY)
    • Sinovac Biotech Ltd (SVA)
    • Zai Lab Ltd (ZLAB)

111 Dividend Yield

Data Unavailable

111 Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -0.71% -5.14%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable